Back to Blog
Publishing
9 min read

How a Medical Resident Got Their First Systematic Review Published in a Q2 Journal

Case study: a medical resident with no methodology training published a systematic review and meta-analysis in a Q2 cardiology journal in 14 weeks with professional support.

Dr. Sarah Mitchell

March 6, 2026

Planning your first systematic review? Use our free PICO framework builder to structure your clinical question.

Key Takeaways

A medical resident with no prior systematic review experience published in a Q2 journal within 14 weeks using professional methodological support

The focused PICO question (intensive vs. standard BP targets in elderly diabetics) made the review scope manageable and clinically relevant

The meta-analysis of 23 RCTs found intensive BP targets reduced cardiovascular events (OR 0.79) but increased serious adverse events (OR 1.42)

PROSPERO registration, comprehensive 5-database searching, and dual-reviewer methodology met the journal's rigorous methodological requirements

The researcher retained full authorship and intellectual ownership while receiving professional methodology and statistical support

The publication was accepted with minor revisions and has been cited 12 times in its first 8 months

Details have been modified to protect client confidentiality. This case study represents a composite of common research scenarios encountered by Research Gold.

A systematic review case study illustrating the complete journey from clinical question to journal acceptance. Dr. A., an internal medicine resident preparing for fellowship applications, needed a first-author publication to strengthen their academic portfolio. They had a compelling clinical question about blood pressure management in elderly patients with diabetes but no experience conducting systematic reviews or meta-analyses.

The Starting Point: A Clinical Question Without a Method

Dr. A. observed conflicting guidance in their hospital's hypertension protocols for diabetic patients over 65. Some attending physicians advocated aggressive targets (below 130/80 mmHg), while others preferred conservative management (below 140/90 mmHg), citing hypotension risks. The clinical uncertainty was genuine and well-suited to evidence synthesis.

However, Dr. A. had never:

Their fellowship application deadline was 16 weeks away. The typical systematic review timeline of 67 weeks was not an option.

Week 1-2: Protocol Development and Registration

The first step was transforming the clinical observation into a structured research question using the PICO framework:

Population: Adults aged 65+ with type 2 diabetes and hypertension Intervention: Intensive blood pressure targets (below 130/80 mmHg) Comparison: Standard blood pressure targets (below 140/90 mmHg) Outcomes: All-cause mortality, cardiovascular events, serious adverse events, renal outcomes

The protocol was drafted using the PROSPERO registration formatter, specifying planned databases, search strategy outline, eligibility criteria, risk of bias tools (RoB 2 for RCTs), planned subgroup analyses (by diabetes duration, baseline blood pressure, and follow-up length), and the meta-analytic model (random-effects, DerSimonian and Laird).

PROSPERO registration was confirmed within 5 business days. This time-stamped public record established the a priori methodology, a requirement for the target Q2 cardiology journal.

A systematic search strategy was developed across five databases: PubMed/MEDLINE, Embase, Cochrane CENTRAL, CINAHL, and ClinicalTrials.gov. The strategy combined MeSH terms and free-text terms for hypertension, diabetes mellitus, blood pressure targets, elderly/aged, and randomized controlled trials.

Using our search strategy builder to structure the Boolean logic, the search retrieved:

  • PubMed: 1,847 records
  • Embase: 2,103 records
  • CENTRAL: 412 records
  • CINAHL: 289 records
  • ClinicalTrials.gov: 196 records

After deduplication, 2,847 unique records entered the screening phase.

Need professional help with your research?

Our PhD methodologists deliver complete systematic reviews and meta-analyses, from protocol to manuscript.

Week 5-7: Screening and Study Selection

Two independent reviewers screened all 2,847 titles and abstracts against the pre-defined eligibility criteria. Inter-rater agreement was strong (Cohen's kappa = 0.82).

  • Title/abstract screening: 2,847 records screened, 127 passed to full-text review
  • Full-text assessment: 127 articles reviewed, 23 randomized controlled trials meeting all eligibility criteria included
  • Exclusion reasons documented for all 104 excluded full-texts

The PRISMA flow chart generator tool documented each stage with precise numbers, ready for manuscript inclusion.

Week 8-10: Data Extraction and Risk of Bias

Two reviewers independently extracted data from all 23 included studies using a standardized extraction form. Extracted variables included: sample sizes per arm, mean blood pressure achieved, follow-up duration, event counts for mortality and cardiovascular endpoints, and adverse event rates.

Risk of bias was assessed using the Cochrane RoB 2 tool across five domains. Of the 23 studies, 9 were rated low risk of bias overall, 11 had some concerns (primarily in the blinding domain, as blood pressure targets are difficult to blind), and 3 were rated high risk.

Dr. A. participated in the data extraction process, verifying clinical details and providing domain expertise on medication classes and blood pressure measurement protocols. This collaboration ensured both methodological rigor and clinical accuracy.

Week 11-12: Meta-Analysis

Meta-analysis was conducted in R using the metafor package. The primary analysis pooled all-cause mortality across 23 studies using a random-effects model (REML estimator), reflecting expected between-study heterogeneity.

Key results:

  • All-cause mortality: OR 0.87 (95% CI: 0.76 to 0.99), favoring intensive targets, I-squared = 41%
  • Cardiovascular events: OR 0.79 (95% CI: 0.71 to 0.88), I-squared = 28%
  • Serious adverse events: OR 1.42 (95% CI: 1.18 to 1.71), higher with intensive targets, I-squared = 52%
  • Renal outcomes: No significant difference, OR 0.94 (95% CI: 0.82 to 1.08)

Forest plots were generated for each outcome. Subgroup analyses examined effects by diabetes duration (less than 10 years vs. 10+ years) and baseline blood pressure level, revealing that the mortality benefit was concentrated in patients with diabetes duration under 10 years.

Sensitivity analyses tested robustness: leave-one-out analysis, exclusion of the 3 high risk-of-bias studies, and comparison of random-effects vs. fixed-effect models. Results were consistent across all sensitivity analyses.

Publication bias assessment using funnel plots and Egger's regression showed no significant asymmetry (p = 0.34), supported by trim-and-fill analysis showing no missing studies.

GRADE summary of findings tables rated all-cause mortality as moderate certainty (downgraded one level for serious risk of bias in some studies) and cardiovascular events as high certainty.

This is the kind of project Research Gold handles regularly. Our systematic review and meta-analysis services take researchers from clinical question to publication-ready manuscript. get a tailored research quote with your research question.

Ready to publish your first systematic review? Research Gold provides the methodological expertise to take you from clinical question to accepted manuscript. Get a free quote.

Week 13-14: Manuscript Preparation and Submission

The manuscript was prepared following the target journal's author guidelines and complete PRISMA 2020 checklist. Supplementary materials included:

  • Full search strategies for all five databases
  • List of excluded studies with reasons
  • Forest plots for all outcomes including subgroup analyses
  • Funnel plots and bias assessment results
  • GRADE evidence profile tables
  • Annotated R analysis code

Dr. A. wrote the clinical interpretation sections of the discussion, placing the findings in the context of current hypertension guidelines (AHA/ACC, ESC/ESH) and their clinical experience.

The Outcome

The manuscript was submitted to a Q2 cardiology journal at week 14. Peer review returned at week 20 with a decision of minor revisions. Reviewer comments were addressed within one week (clarifying the subgroup analysis rationale and adding a requested sensitivity analysis). The manuscript was accepted for publication at week 22.

Dr. A. included this first-author publication on their fellowship application, which was submitted on time. The review has since been cited 12 times in the first 8 months post-publication.

Lessons from This Case

  1. A focused PICO question made the review manageable. Dr. A.'s initial question was too broad; narrowing to a specific population and comparison made it publishable.
  2. Professional support compressed the timeline from the typical 67 weeks to 14 weeks without compromising methodology.
  3. The researcher retained full authorship and intellectual ownership. Dr. A. conceived the question, directed clinical decisions, wrote interpretation sections, and approved the final manuscript.
  4. PROSPERO registration was essential for journal submission, establishing methodological credibility.
  5. Fellowship applications benefit from a published systematic review demonstrating research capability and clinical relevance.

Explore our systematic review services or request a free consultation to discuss your research project. View transparent pricing and see how the process works.

Inspired by this case study? Our step-by-step guide explains how to complete a systematic review during residency alongside clinical duties.

Not sure what to study? Browse 30 research project ideas organized by specialty for inspiration.

If fellowship is your goal, find out how many publications fellowship programs expect and how to reach that target.

Frequently Asked Questions

4
Yes. Medical residents regularly publish systematic reviews, often as first authors. Professional methodology support compresses the timeline and ensures the review meets journal standards, while the resident provides the clinical question and domain expertise.
Typically 10 to 16 weeks from protocol to submission-ready manuscript. Journal peer review adds additional time (typically 4-12 weeks depending on the journal). In this case, from start to acceptance took 22 weeks total.
Yes. Under ICMJE guidelines, you retain full first authorship because you conceived the research question, directed clinical decisions, and approved the final manuscript. Professional methodological support is acknowledged appropriately.
A published first-author systematic review demonstrates research capability, evidence-based thinking, and the ability to complete a project. Fellowship committees value these qualities, particularly when the review addresses a clinically relevant question in the specialty.
Share

Found this useful? Share it with your colleagues.

Need professional help with your research?

Our PhD methodologists deliver complete systematic reviews and meta-analyses, from protocol to manuscript.

Explore our Systematic Review Service, handled end-to-end by a PhD methodologist.

Professional Support

Let a PhD Expert Handle Your Research

From protocol to publication-ready manuscript. Our PhD-level methodologists handle systematic reviews, meta-analyses, scoping reviews, and more. Most projects deliver in under 2 weeks.

Our promise: Free rework on search, screening, or synthesis if reviewers push back.

4.9 / 5Quote within a few hoursPRISMA 2020 + Cochrane HandbookPhD methodologistConfidential by default
Chat on WhatsApp now
DS

Written by

Dr. Sarah Mitchell

PhD, Biostatistics & Research Methodology
Systematic Review MethodologyMeta-AnalysisBiostatistics

Dr. Sarah Mitchell holds a PhD in Biostatistics from Johns Hopkins Bloomberg School of Public Health and has over 15 years of experience in systematic review methodology and meta-analysis. She has authored or co-authored 40+ peer-reviewed publications in journals including the Journal of Clinical Epidemiology, BMC Medical Research Methodology, and Research Synthesis Methods. A former Cochrane Review Group statistician and current editorial board member of Systematic Reviews, Dr. Mitchell has supervised 200+ evidence synthesis projects across clinical medicine, public health, and social sciences.

Research Gold has helped medical residents, fellows, and clinician-researchers publish systematic reviews in Q1 and Q2 journals. See our process or view pricing.

Let a PhD Expert Handle Your Research

From protocol to publication-ready manuscript. Our PhD-level methodologists handle systematic reviews, meta-analyses, scoping reviews, and more. Most projects deliver in under 2 weeks.

Quote within a few hours. Pay only after you approve your quote. Unlimited revisions within your agreed scope. Confidential by default.